Effect of rocuronium-sugammadex versus cisatracurium on motor evoked potentials (RECAP-MEP)-A randomized controlled trial
Surgical Neurology International · 05.09.2025 · 16 · 384
DOI: 10.25259/sni_765_2025 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Surgical Neurology International, online erschienen am 05.09.2025. Verfasst von Sapna Suresh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesia and Critical Care, Aster Medicity, Kochi, Kerala, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transcranial motor-evoked potentials (TcMEPs) are essential for monitoring spinal cord integrity during spine surgery, but are highly sensitive to neuromuscular blocking agents. This study compared the effects of rocuronium reversed with sugammadex versus cisatracurium on TcMEP amplitude and recovery characteristics during thoracic and lumbar spine surgery.
Methods
A double-blinded, randomized controlled trial was conducted in 60 patients undergoing elective spine surgery. Participants were randomized to receive either rocuronium 0.6 mg/kg with sugammadex reversal (Group R, n = 30) or cisatracurium 0.15 mg/kg (Group C, n = 30). Primary outcomes included MEP amplitude and latency at 5, 10, 20, 30, and 60 min post-obtaining the fourth twitch in the train-of-four (TOF) sequence with a peripheral nerve stimulator. Secondary outcomes measured TOF recovery times and intraoperative adverse events. Data were presented as mean ± standard deviation. The normally distributed continuous variables were compared using Student’s t-test, with P < 0.05 considered statistically significant.
Results
Group R demonstrated significantly higher MEP amplitudes and shorter MEP latency at all time points from baseline till 30 min as compared to group C ( P < 0.05). TOF recovery was significantly faster in group R ( P < 0.001) as compared to group C. Group R had a higher incidence of nociception-induced movements ( P = 0.076) and excessive field movements ( P = 0.118), which was not statistically significant. The total propofol dosage in group R was significantly higher ( P = 0.042) compared to group C. No postoperative neurological deficits occurred in either group.
Conclusion
At similar TOF ratios, sugammadex-facilitated reversal of rocuronium results in superior quality of MEP parameters, such as higher MEP amplitude and shorter MEP latency, with no significant difference in adverse movements compared to single-dose cisatracurium.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anesthesia and Critical Care, Aster Medicity, Kochi, Kerala, India.
- Neuroanesthesia and Critical Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
- Department of Neurosurgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Zitieren
APA
Suresh, S., Hrishi, A. P., Thiruvathra, J., & Divakar, G. (2025). Effect of rocuronium-sugammadex versus cisatracurium on motor evoked potentials (RECAP-MEP)-A randomized controlled trial. Surgical Neurology International, 16, 384. https://doi.org/10.25259/sni_765_2025
Vancouver
Suresh S, Hrishi AP, Thiruvathra J, Divakar G. Effect of rocuronium-sugammadex versus cisatracurium on motor evoked potentials (RECAP-MEP)-A randomized controlled trial. Surgical Neurology International. 2025;16:384. doi:10.25259/sni_765_2025
BibTeX
@article{Suresh2025,
author = {Suresh, Sapna and Hrishi, Ajay Prasad and Thiruvathra, Jithendra and Divakar, Ganesh},
title = {Effect of rocuronium-sugammadex versus cisatracurium on motor evoked potentials (RECAP-MEP)-A randomized controlled trial},
journal = {Surgical Neurology International},
year = {2025},
volume = {16},
pages = {384},
doi = {10.25259/sni_765_2025}
}
EUVIMED